OncoSec Medical Company Profile (NASDAQ:ONCS)

About OncoSec Medical

OncoSec Medical logoOncoSec Medical Incorporated is a biotechnology company focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer. The Company's portfolio includes biologic immunology therapeutic product candidates intended to treat a range of tumor types. The Company's technology includes property relating to its ImmunoPulse delivery technology. The Company's ImmunoPulse is an electroporation delivery device that the Company uses in combination with its therapeutic product candidates, including deoxyribonucleic acid (DNA) plasmids that encode for immunologically active agents, to deliver the therapeutic directly into the tumor and promote an inflammatory response against the cancer. Its electroporation devices consist of an electrical pulse generator and disposable applicators. The Company's ImmunoPulse product candidates are based on its DNA based immunotherapy technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ONCS
  • CUSIP:
Key Metrics:
  • Previous Close: $1.68
  • 50 Day Moving Average: $1.76
  • 200 Day Moving Average: $1.91
  • 52-Week Range: $1.36 - $6.94
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.19
  • P/E Growth: 0.00
  • Market Cap: $29.63M
  • Outstanding Shares: 17,636,000
  • Beta: 2.23
Additional Links:
Companies Related to OncoSec Medical:

Analyst Ratings

Consensus Ratings for OncoSec Medical (NASDAQ:ONCS) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $9.33 (453.91% upside)

Analysts' Ratings History for OncoSec Medical (NASDAQ:ONCS)
Show:
DateFirmActionRatingPrice TargetDetails
7/21/2016Maxim GroupDowngradeBuy$17.00 -> $5.00View Rating Details
7/21/2016Rodman & RenshawInitiated CoverageBuy$6.00View Rating Details
4/20/2016HC WainwrightReiterated RatingBuyView Rating Details
(Data available from 8/30/2014 forward)

Earnings

Earnings History for OncoSec Medical (NASDAQ:ONCS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/12/2016        
6/9/2016Q316($0.43)($0.37)ViewN/AView Earnings Details
3/8/2016Q216($0.46)($0.42)ViewN/AView Earnings Details
12/8/2015Q116($0.48)($0.47)ViewN/AView Earnings Details
10/14/2015Q415($0.40)($0.48)ViewListenView Earnings Details
3/12/2015($0.02)($0.02)ViewN/AView Earnings Details
12/8/2014($0.02)($0.02)ViewN/AView Earnings Details
10/13/2014($0.01)($0.01)ViewN/AView Earnings Details
6/16/2014($0.01)($0.02)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for OncoSec Medical (NASDAQ:ONCS)
Current Year EPS Consensus Estimate: $-1.58 EPS
Next Year EPS Consensus Estimate: $-1.42 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.43)($0.43)($0.43)
Q2 20161($0.44)($0.44)($0.44)
Q3 20161($0.45)($0.45)($0.45)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for OncoSec Medical (NASDAQ:ONCS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for OncoSec Medical (NASDAQ:ONCS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/16/2015Punit DhillonCEOBuy10,000$4.25$42,500.00View SEC Filing  
6/10/2015Punit DhillonCEOBuy2,500$6.74$16,850.00View SEC Filing  
3/20/2014Anthony E Maida IIIDirectorBuy22,800$0.81$18,468.00View SEC Filing  
3/19/2014Punit DhillonCEOBuy50,000$0.80$40,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for OncoSec Medical (NASDAQ:ONCS)
DateHeadline
News IconHow the Crowd & Sell-side View OncoSec Medical Inc (NASDAQ:ONCS) Shares - Post News (NASDAQ:ONCS)
www.kentuckypostnews.com - August 23 at 6:49 PM
publicnow.com logoOncoSec Announces Peer-Reviewed Publication of T-Cell Exhaustion Marker to Predict Response to Anti-PD-1 Therapy in Melanoma (NASDAQ:ONCS)
www.publicnow.com - August 15 at 6:58 PM
ftsenews.co.uk logoOncoSec Medical (ONCS) Updated Price Targets - FTSE News (NASDAQ:ONCS)
www.ftsenews.co.uk - August 8 at 6:51 PM
fortune.com logoOncoSec Medical Incorporated (NASDAQ:ONCS) Stock Rises, Analysts: Hold Rating - Review Fortune (NASDAQ:ONCS)
reviewfortune.com - August 1 at 11:19 AM
breakingfinancenews.com logoOncosec (NASDAQ:ONCS) price target reduced to $5 as covered today by Maxim Group - Breaking Finance News (NASDAQ:ONCS)
breakingfinancenews.com - July 24 at 6:08 PM
News IconInvestor Update: Earnings and Target Price Recap on OncoSec Medical Inc (NASDAQ:ONCS) - Press Telegraph (NASDAQ:ONCS)
presstelegraph.com - July 22 at 6:31 PM
benzinga.com logoRodman & Renshaw Sees 243% Upside In OncoSec Medical Shares - Benzinga (NASDAQ:ONCS)
www.benzinga.com - July 22 at 6:31 PM
News IconChecking in on Stock Volatility for: OncoSec Medical Incorporated (NASDAQ:ONCS) - Engelwood Daily (NASDAQ:ONCS)
www.engelwooddaily.com - July 22 at 6:31 PM
News IconOncoSec Medical Inc (NASDAQ:ONCS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:ONCS)
www.engelwooddaily.com - July 21 at 9:32 AM
News IconOncoSec Medical Inc (NASDAQ:ONCS) Wall Street Analyst Recommendation Outlook - TGP (NASDAQ:ONCS)
telanaganapress.com - July 19 at 8:01 AM
News IconWhat's Ahead for OncoSec Medical Inc After Forming Multiple Bottom Chart Pattern? - Consumer Eagle (NASDAQ:ONCS)
www.consumereagle.com - July 15 at 5:41 PM
News IconWall Street Ratings and Target Price Views on OncoSec Medical Inc (NASDAQ:ONCS) - Telanagana Press (NASDAQ:ONCS)
telanaganapress.com - July 11 at 6:38 PM
News IconCan OncoSec Medical Inc (NASDAQ:ONCS) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:ONCS)
www.engelwooddaily.com - July 8 at 9:35 AM
News IconOncosec Medical (NASDAQ:ONCS) Short Interest Decreased By 16.03% - Engelwood Daily (NASDAQ:ONCS)
www.engelwooddaily.com - July 2 at 9:25 AM
biz.yahoo.com logoONCOSEC MEDICAL INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Financial Statements and Exhi (NASDAQ:ONCS)
biz.yahoo.com - July 1 at 5:01 PM
News IconWatching Stock Volatility for: OncoSec Medical Incorporated (NASDAQ:ONCS) - Engelwood Daily (NASDAQ:ONCS)
www.engelwooddaily.com - June 29 at 6:33 PM
News IconOncosec Medical (NASDAQ:ONCS) Short Interest Decreased By 16.03% - Press Telegraph (NASDAQ:ONCS)
presstelegraph.com - June 28 at 11:30 AM
News IconCovering the Bases on OncoSec Medical Inc (NASDAQ:ONCS): Where is the Stock Going? - Press Telegraph (NASDAQ:ONCS)
presstelegraph.com - June 28 at 11:30 AM
publicnow.com logoOncoSec Presents Significant Advancements in Electroporation Technology for Immunotherapy (NASDAQ:ONCS)
www.publicnow.com - June 28 at 9:41 AM
News IconRevenue Update on OncoSec Medical Inc(NASDAQ:ONCS) - TheFounders Daily (NASDAQ:ONCS)
www.thefoundersdaily.com - June 18 at 10:51 AM
smarteranalyst.com logoCompany Update (NASDAQ:ONCS): OncoSec Medical Inc Presents Preliminary Findings from Head and Neck Phase II ... - Smarter Analyst (NASDAQ:ONCS)
www.smarteranalyst.com - June 18 at 10:51 AM
News IconBiotechs Setup To Bounce Once Again (NASDAQ:ONCS)
www.ssuchronicle.com - June 16 at 6:52 PM
publicnow.com logoOncoSec Presents Preliminary Findings from Head and Neck Phase II Clinical Trial at EUROGIN 2016 Conference (NASDAQ:ONCS)
www.publicnow.com - June 16 at 10:39 AM
publicnow.com logoOncoSec Announces Third Quarter and YTD Results for Fiscal Year 2016 (NASDAQ:ONCS)
www.publicnow.com - June 9 at 4:19 PM
kcregister.com logoColony Capital, Inc. (NYSE:CLNY) Rose 2.96%: OncoSec Medical Incorporated (NASDAQ:ONCS), PetMed Express ... - KC Register (NASDAQ:ONCS)
www.kcregister.com - June 8 at 7:01 PM
streetinsider.com logoOncosec Medical (ONCS) Shows Utility of T-cell Exhaustion Marker to Predict Response to Anti-PD-1 Monotherapies - StreetInsider.com (NASDAQ:ONCS)
www.streetinsider.com - June 6 at 6:34 PM
4-traders.com logoOncoSec Medical : Collaborators Present Results of Novel T-Cell Exhaustion Marker to Predict Response to Anti-PD-1 Monotherapy (NASDAQ:ONCS)
www.4-traders.com - June 6 at 10:21 AM
publicnow.com logoOncoSec Collaborators Present Results of Novel T-Cell Exhaustion Marker to Predict Response to Anti-PD-1 Monotherapy (NASDAQ:ONCS)
www.publicnow.com - June 6 at 6:28 AM
uk.finance.yahoo.com logoOncoSec Medical Incorporated's CEO Punit Dhillon Interviewed by The Life Sciences Report - Yahoo Finance UK (NASDAQ:ONCS)
uk.finance.yahoo.com - June 3 at 7:08 PM
News IconStock Review and Earnings Check on OncoSec Medical Inc (NASDAQ:ONCS) - HNN (NASDAQ:ONCS)
hintsnewsnetwork.com - June 3 at 9:31 AM
News IconBroker Watchlist: OncoSec Medical (ONCS) - Share Trading News (NASDAQ:ONCS)
www.sharetrading.news - June 2 at 7:01 PM
finance.yahoo.com logoOncoSec Medical Incorporated's CEO Punit Dhillon Interviewed by The Life Sciences Report (NASDAQ:ONCS)
finance.yahoo.com - June 2 at 10:57 AM
News IconOncoSec Medical Inc's Stock Formed A Several Months Bearish Multiple Bottom - HNN (NASDAQ:ONCS)
hintsnewsnetwork.com - June 2 at 9:36 AM
publicnow.com logoOncoSec to Present at Scientific and Investment Conferences in June (NASDAQ:ONCS)
www.publicnow.com - June 1 at 6:23 AM
News IconShare Rating Focus on OncoSec Medical Inc (NASDAQ:ONCS) - HNN (NASDAQ:ONCS)
hintsnewsnetwork.com - May 31 at 10:30 AM
smarteranalyst.com logoStock Update (NASDAQ:ONCS): OncoSec Medical Inc Closes $10 Million At-The-Market Registered Direct Offering - Smarter Analyst (NASDAQ:ONCS)
www.smarteranalyst.com - May 28 at 3:24 AM
publicnow.com logoOncoSec Closes $10 Million At-The-Market Registered Direct Offering (NASDAQ:ONCS)
www.publicnow.com - May 26 at 8:37 PM
biz.yahoo.com logoONCOSEC MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secur (NASDAQ:ONCS)
biz.yahoo.com - May 24 at 5:22 PM
News IconFriday's Mid-Day Movers: Linn Energy (LINE), Breitburn Energy Partners (BBEP), OncoSec Medical Inc (ONCS ... - Analyst Ratings (NASDAQ:ONCS)
www.analystratings.com - May 22 at 1:20 PM
prnewswire.com logoOncoSec to Host Third Quarter Financial Results Conference Call on June 9, 2016 - PR Newswire (press release) (NASDAQ:ONCS)
www.prnewswire.com - May 18 at 10:26 PM
kcregister.com logoMorning Watch List: Prologis, Inc. (NYSE:PLD), OncoSec Medical Incorporated (NASDAQ:ONCS), MannKind Corp ... - KC Register (NASDAQ:ONCS)
www.kcregister.com - May 17 at 8:21 PM
News IconOncosec Medical (NASDAQ:ONCS) Short Interest Increased By 14.56% - B.O.D.Y Confidential (NASDAQ:ONCS)
www.bodyconfidential.com - May 11 at 11:00 PM
News IconEarnings Outlook on OncoSec Medical Inc (NASDAQ:ONCS) - B.O.D.Y Confidential (NASDAQ:ONCS)
www.bodyconfidential.com - May 5 at 11:07 PM
News IconOncosec Medical (NASDAQ:ONCS) Shorted Shares Increased By 14.56% - B.O.D.Y Confidential (NASDAQ:ONCS)
www.bodyconfidential.com - May 3 at 1:27 AM
kcregister.com logoShining on Major News: OncoSec Medical Incorporated (NASDAQ:ONCS), Chimera Investment Corporation (NYSE ... - KC Register (NASDAQ:ONCS)
www.kcregister.com - May 3 at 1:27 AM
News IconOncoSec Medical Inc (NASDAQ:ONCS) Wall Street Rating in Focus - News Tribune (NASDAQ:ONCS)
www.greenvilletribune.com - April 27 at 10:59 PM
News IconOncoSec Medical Inc (NASDAQ:ONCS) Share Rating Recap - B.O.D.Y Confidential (NASDAQ:ONCS)
www.bodyconfidential.com - April 26 at 9:24 PM
noodls.com logoOncoSec Medical Closes $7.5 Million Registered Direct Offering (NASDAQ:ONCS)
www.noodls.com - November 9 at 4:26 PM
noodls.com logoOncoSec Announces $7.5 Million Registered Direct Offering (NASDAQ:ONCS)
www.noodls.com - November 3 at 8:17 PM
noodls.com logoOncoSec Enrolls First Patient in Biomarker-Focused Pilot Study in Triple Negative Breast Cancer (NASDAQ:ONCS)
www.noodls.com - October 29 at 6:28 AM

Social

OncoSec Medical (NASDAQ:ONCS) Chart for Tuesday, August, 30, 2016


Last Updated on 8/30/2016 by MarketBeat.com Staff